Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

414 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Use of Vedolizumab in Preventing Postoperative Recurrence of Crohn's Disease.
Yamada A, Komaki Y, Patel N, Komaki F, Pekow J, Dalal S, Cohen RD, Cannon L, Umanskiy K, Smith R, Hurst R, Hyman N, Rubin DT, Sakuraba A. Yamada A, et al. Among authors: cohen rd. Inflamm Bowel Dis. 2018 Feb 15;24(3):502-509. doi: 10.1093/ibd/izx054. Inflamm Bowel Dis. 2018. PMID: 29462385
Maneuvering Clinical Pathways for Crohn's Disease.
Lu TX, Cohen RD. Lu TX, et al. Among authors: cohen rd. Curr Gastroenterol Rep. 2019 Apr 23;21(5):20. doi: 10.1007/s11894-019-0687-4. Curr Gastroenterol Rep. 2019. PMID: 31016466 Free PMC article. Review.
Outcome of elective switching to vedolizumab in inflammatory bowel disease patients under tumor necrosis factor antagonist-maintained clinical remission.
Wang Y, Wang J, Pekow J, Dalal S, Cohen RD, Ollech J, Israel A, Shogan BD, Micic D, Cannon L, Umanskiy K, Hurst R, Hyman N, Rubin DT, Sakuraba A. Wang Y, et al. Among authors: cohen rd. J Gastroenterol Hepatol. 2019 Dec;34(12):2090-2095. doi: 10.1111/jgh.14751. Epub 2019 Jun 28. J Gastroenterol Hepatol. 2019. PMID: 31169926
414 results